Brief: Heron Therapeutics Announces Financial Results For The Three, Nine Months Ended September 30, 2022

Heron Therapeutics

08/11/2022 23:23

Nov 8 (Reuters) - Heron Therapeutics Inc  HRTX.O :
    * HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE AND
NINE MONTHS ENDED SEPTEMBER 30, 2022 AND HIGHLIGHTS RECENT
CORPORATE UPDATES
    * HERON THERAPEUTICS - QTRLY LOSS PER SHARE $0.38
    * HERON THERAPEUTICS - QTRLY NET SALES $26.6 MILLION VERSUS
$23.2
MILLION
    * Q3 EARNINGS PER SHARE VIEW $-0.38, REVENUE VIEW $27.0
MILLION --
REFINITIV IBES DATA
    * HERON THERAPEUTICS - APONVIE™ APPROVAL BY FDA, U.S. LAUNCH
PLANNED FOR Q1 2023
    * HERON THERAPEUTICS - ZYNRELEF® UNIT DEMAND GREW 18% OVER
PRIOR
QUARTER IN Q3 2022

Source text for Eikon:  ID:nPnbnc7HRa 
Further company coverage:  HRTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))